On Monday, DocuSign hit an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 90-plus percentile with an improvement to 94, up from 88 the day before.
IBD's unique RS Rating identifies market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history reveals that the best stocks tend to have an 80 or better RS Rating as they launch their largest climbs.
Looking For The Best Stocks To Buy And Watch? Start Here
DocuSign is trying to complete a consolidation with a 107.86 buy point. See if the stock can break out in volume at least 40% higher than normal.
EPS growth fell last quarter from 14% to 13%, but the top line rose from 8% to 9%.
The company earns the No. 3 rank among its peers in the Computer Software-Enterprise industry group. Palantir Technologies is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
